CGN Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
ECSS
CGN Advisors's MRK Position: Q2 2026 in Review
CGN Advisors reduced its Merck (MRK) stake by 2.3% in Q2 2026, selling an estimated $76.5K and leaving 27,689 shares worth $3.56M. The position accounts for 0.26% of the portfolio, ranked #75.
CGN Advisors first reported a position in MRK in Q4 2020 and has held it in 20 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- CGN Advisors held 27,689 shares of Merck worth $3.56M as of Q2 2026.
- CGN Advisors sold 654 Merck shares in Q2 2026, an estimated $76.5K.
- Merck made up 0.26% of CGN Advisors's portfolio in Q2 2026, its #75 holding.
- CGN Advisors first reported a position in Merck in Q4 2020 and has held it in 20 quarters since.
- 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on CGN Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.